What Are the Most Common Peptide Scams?

Published August 27, 2026 · Artemis Labs

Research Buyer FAQ › Choosing a Peptide Supplier & the Enforcement Record › Scam Red Flags

Four patterns account for most research-peptide fraud: forged or reused Certificates of Analysis, vials with no lot number, lookalike sites trading on dead vendors’ names, and coded product naming. None of these are hypothetical — each appears in the documented enforcement record of 2024–2026, and this page cites that record rather than inventing examples.

How this page was built. Every case fact below traces to a court filing, an agency letter, or a company’s own published statement, via the linked write-ups. Allegations are described as allegations and attributed to the document that makes them. Sources are under References.

What are the most common peptide scams?

The four patterns share one mechanic: each one breaks the link between the vial in your hand and any document that could vouch for it. A forged or reused Certificate of Analysis makes the paperwork itself a lie. A missing lot number makes even honest paperwork unmatchable. A lookalike site makes the vendor a lie. Coded product naming hides what is being sold from the systems that would otherwise notice.

All four became more common after the 2026 closures, when the market’s largest names disappeared and their search traffic went looking for successors. That is the moment fraud favours: buyers in motion, brands unclaimed, and nobody yet sure who is real. The vendor-by-vendor chronology behind this page is in our April 2026 FDA warning-letter batch write-up and its companion posts.

How do forged Certificates of Analysis work?

The documented version comes from the Paradigm Peptides prosecution, and it is blunter than most buyers imagine. The federal charging document in that case states that the defendants forged Certificates of Analysis “by editing the information and watermarks on other businesses’ Certificates of Analysis” — real labs’ documents, altered to vouch for products those labs never saw. The same filing charges that some products labelled as SARMs were found by FDA lab testing to contain testosterone, a Schedule III controlled substance, not declared on the label. Those statements are the government’s charges; the owner, Matthew Kawa, pleaded guilty on December 10, 2025 and was sentenced on July 30, 2026.

The lesson is not “check whether the COA exists.” Paradigm’s customers had COAs. The lesson is that a Certificate of Analysis is only as good as its provenance: which lab issued it, whether that lab is independent and reachable, and whether the document’s lot code matches the vial in front of you. A certificate that fails any of those is a picture of a certificate. The full case record is in the Paradigm Peptides case record.

Why is a missing lot number a red flag?

Because a vial with no lot number cannot be matched to any test report, ever. The entire verification chain — this vial, from this batch, tested by this lab, on this date — hangs on that one code. Remove it and every document the vendor shows you becomes unfalsifiable: it might describe your vial, or any vial, or none.

A missing lot is cheaper than a forged document and accomplishes the same thing, which is why it is the more common finding. It also has no innocent version at scale. Any producer running real per-batch testing needs lot codes for their own records; a catalog full of unmarked vials is telling you the records do not exist.

Is that Peptide Sciences site still real?

No. Peptide Sciences announced its closure on March 6, 2026, and its own closure notice stated that any further sales under its brand are fraudulent. That statement is the company’s, not ours — which makes the conclusion unusually clean: a site trading under that name today is, by the brand owner’s own published word, not the company. Unaffiliated sites reusing the branding have appeared since. How to recognise them is covered in our write-up on unaffiliated sites reusing Peptide Sciences branding.

What does a lookalike site look like?

It looks like the original, which is the point — the scam is typosquatting on a dead vendor’s reputation. After Paradigm Peptides’ site went down in March 2024, a similarly-named domain appeared, itself stating it had no affiliation with the original company. Whoever runs such a site, the buyer’s situation is the same: the reputation that made the name worth copying belongs to an entity that no longer exists, so the name now vouches for nothing.

The check is boring and works: a closed vendor’s brand cannot come back to life quietly. If a company announced its closure and a site under that name is taking orders, the site’s own existence contradicts the record. When in doubt, search the dated record — our supplier and enforcement-record page keeps the chronology current.

Why are coded product names a warning sign?

Because of what they are for. Some vendors list compounds under abbreviations and invented names rather than the compound’s actual name. The FDA’s March 31, 2026 warning letters address this directly: the agency identified every compound behind the coded listings and described the coding as circumvention rather than cover. A vendor obscuring what it sells is not protecting you — it is routing around the payment processors, marketplaces and regulators that would object to the real name, and it is telling you the vendor expects that objection.

For a buyer there is also a plainer problem: you cannot verify a product whose identity is a nickname. No published research, no test report, and no COA can be matched to a name that exists only in one vendor’s catalog.

What do I do if I got a fake peptide?

Stop using the material for any work, and keep everything — vial, label, packaging, paperwork. Then establish what you actually have. Does the lot code on the vial match the lot code on the Certificate of Analysis? Does that certificate name a lab, a method, and a test date? Ask the vendor directly for the batch report and the testing lab’s name; a vendor who cannot produce either has answered you.

If you paid by card or a payment app, open a dispute while the window is open — the transaction record is evidence, which is part of why you kept the paperwork. A suspect product can also be reported to the FDA through its report a problem channel. None of this recovers a bad batch, but the report is how patterns like the ones on this page enter the record that protects the next buyer.

The positive version of this page — the six checks that verify a supplier before any of these patterns can reach you — is on the parent page, Choosing a Peptide Supplier & the Enforcement Record. This page is one section of the full Artemis Labs research-buyer FAQ.

References

  1. United States v. Kawa, No. 3:25-cr-00091 (N.D. Ind.) — two-count felony Information, filed October 27, 2025, ¶18 (charged false representations including forged Certificates of Analysis) and ¶19 (FDA lab testing; undeclared testosterone). Charging document via CourtListener/RECAP
  2. CBS News — “Peptides seller sentenced to prison for selling unapproved drugs” (Paradigm Peptides; pleas December 10, 2025; sentencing July 30, 2026, N.D. Indiana). cbsnews.com
  3. US FDA — Warning Letters database, including the March 31, 2026 batch (seven sites, posted April 7, 2026). fda.gov warning letters database
  4. US FDA — Report a Problem to FDA. fda.gov/safety/report-problem-fda

All compounds sold by Artemis Labs are for laboratory research use only. Nothing on this page is medical advice, and no statement has been evaluated by the FDA.